Comic Book Debuts at Florida Supercon to Honor Heroes Who Save the Lives of Blood Cancer Patients prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Many South Africans with blood diseases and cancers are dying because they cannot find bone marrow donors.
Finding a suitable bone marrow donor is extremely difficult.
Hereditary matters in finding a match and donors are usually found within the patient’s population group.
But only 30% of donors are people of colour.
The South African Bone Marrow Registry is urgently seeking more people of colour to register as donors.
Great advances have been made and today most bone marrow donations are done through a non-invasive process.
The South African Bone Marrow Registry (SABMR) is urgently seeking more people of colour to register as donors to help give more South Africans a better shot at a second chance at life.
Gaensel Energy Group, Inc. (GEGR) Acquires SSCB Swiss Stem Cells Biotech, the Only Private Stem Cell Biobank in Switzerland
Gaensel Energy Group, Inc.
https://orders.newsfilecorp.com/files/7475/77566 d11048e994f20a54 001full.jpg
Swiss Stem Cells Biotech
https://orders.newsfilecorp.com/files/7475/77566 d11048e994f20a54 002full.jpg
The Company is pleased to announce the first of at least 2 acquisitions in the Biotech Industry.
SSCB is a world renowned participant in Stem Cell Technology and places Gaensel in the front of this exciting and revolutionary health technology.
The Board expressed its pleasure working with the President Claudio Massa where he and his advisors have worked tirelessly over the past ninety days to ensure the success of the negotiations and final agreements being completed. The Shareholders of Gaensel will see the long term value this new partnership brings to the Company.
ResearchAndMarkets.com’s offering.
From the early 1900s through the mid-2000s, the global cord blood banking industry proliferated with cord blood banks emerging in all major healthcare markets worldwide. From 2005 to 2010, the market reached saturation and stabilized. From 2010 to 2020, the market began to aggressively consolidate, creating both threats and opportunities within the industry.
Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular therapies, and an increasing trend toward industry consolidation. Opportunities for the industry include price efficiencies associated with scale and consolidation, accelerated regulatory pathways for cord blood and tissue-based cell therapies, and progress with
Share this article
Share this article
ResearchAndMarkets.com s offering.
From the early 1900s through the mid-2000s, the global cord blood banking industry proliferated with cord blood banks emerging in all major healthcare markets worldwide. From 2005 to 2010, the market reached saturation and stabilized. From 2010 to 2020, the market began to aggressively consolidate, creating both threats and opportunities within the industry.
Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular therapies, and an increasing trend toward industry consolidation. Opportunities for the industry include price efficiencies associated with scale and consolidation, accelerated regulatory pathways for cord blood and tissue-based cell therapies, and progress with